M.D.C. Holdings, Inc.
MDC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.72 | -0.33 | -1.25 | 0.13 |
| FCF Yield | -1.77% | 12.77% | 39.05% | -6.07% |
| EV / EBITDA | 13.60 | 7.51 | 4.06 | 6.29 |
| Quality | ||||
| ROIC | 5.53% | 6.90% | 11.72% | 13.52% |
| Gross Margin | 619.61% | 19.64% | 22.92% | 24.06% |
| Cash Conversion Ratio | -0.21 | 1.40 | 1.61 | -0.36 |
| Growth | ||||
| Revenue 3-Year CAGR | -70.37% | -4.04% | 13.59% | 16.85% |
| Free Cash Flow Growth | -116.08% | -40.85% | 468.80% | -376.59% |
| Safety | ||||
| Net Debt / EBITDA | -2.01 | 0.15 | 1.21 | 1.43 |
| Interest Coverage | 0.00 | 6.89 | 120.34 | 11.67 |
| Efficiency | ||||
| Inventory Turnover | -0.21 | 1.13 | 1.25 | 1.06 |
| Cash Conversion Cycle | -1,661.00 | 317.24 | 285.56 | 334.91 |